Dashenlin Pharmaceutical Group Co., Ltd. Class ASSE: 603233

Indicative Announcement on Suspending Conversion of “Dashenlin Convertible Bonds" during the Implementation of Semi-annual Dividend Distribution for 2025

· Issued by Dashenlin Pharmaceutical Group Co., Ltd. Class A via Shanghai Stock Exchange
Indicative Announcement on Suspending Conversion of “Dashenlin Convertible Bonds" during the Implementation of Semi-annual Dividend Distribution for 2025

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment